Catherine Ramsey
Stock Analyst at Baird
(3.65)
# 779
Out of 5,148 analysts
56
Total ratings
51.22%
Success rate
9.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $239 → $257 | $200.17 | +28.39% | 7 | Feb 27, 2026 | |
| CSTL Castle Biosciences | Maintains: Outperform | $41 → $44 | $27.99 | +57.20% | 10 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $132.89 | -17.98% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $95.59 | +28.67% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $307.23 | +14.57% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $45.89 | -4.12% | 7 | May 6, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $508.58 | +30.76% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $118.17 | +35.40% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $103.35 | -27.43% | 1 | Aug 3, 2022 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $200.17
Upside: +28.39%
Castle Biosciences
Feb 27, 2026
Maintains: Outperform
Price Target: $41 → $44
Current: $27.99
Upside: +57.20%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $132.89
Upside: -17.98%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $95.59
Upside: +28.67%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $307.23
Upside: +14.57%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $45.89
Upside: -4.12%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $508.58
Upside: +30.76%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $118.17
Upside: +35.40%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $103.35
Upside: -27.43%